A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast Cancer
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to test whether treatment of patients with advanced or
metastatic solid tumors or breast cancer with Abraxane plus Vidaza is safe and results in
good tumor response. All patients enrolling in this study will receive treatment with
Abraxane and Vidaza. Safety will be assessed by adverse events, laboratory results and
performance status. Tumor response will be measured by RECIST criteria.